Safety and Tolerability of BION-1301 in Adults With Relapsed or Refractory Multiple Myeloma (MM)
Clinical trial NCT03340883 · TERMINATED
Trial details
- NCT number
- NCT03340883
- Sponsor
- Chinook Therapeutics, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-15
- Primary completion
- 2019-06-13
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.